The Effects of Short-term Preoperative Treatment With Hormonal Therapy on Gene Profiles in Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Trials Related to Letrozole
Related studies linked through entity extraction aliases.
A Window-of-opportunity Study of Pelareorep in Early Breast Cancer
- Status
- TERMINATED
- Phase
- EARLY_PHASE1
A Phase Ⅱ Trial of Pyrotinib Combination With CDK4/6 Inhibitor SHR6390 in Patients Prior Trastuzumab-treated Advanced HER2-Positive Breast Cancer
- Status
- UNKNOWN
- Phase
- PHASE2
Letrozole With or Without Paclitaxel and Carboplatin in Treating Patients With Stage II-IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Phase 2 Study of Amcenestrant (SAR439859) Versus Physician's Choice in Locally Advanced or Metastatic ER-positive Breast Cancer
- Status
- TERMINATED
- Phase
- PHASE2
Abemaciclib and Letrozole in Treating Patients With Endometrial Cancer
- Status
- COMPLETED
- Phase
- EARLY_PHASE1
Palbociclib Combined With an Aromatase Inhibitor in Breast Cancer
- Status
- UNKNOWN
- Phase
- PHASE3
Letrozole for Frozen Embryo Transfer (FET) in Patients With Polycystic Ovary Syndrome (PCOS)
- Status
- WITHDRAWN
- Phase
- PHASE4
Assessment and Prevention of Pain During Ovarian Stimulation in Patients With Endometriosis
- Status
- COMPLETED
- Phase
- PHASE2
A 2-Week Ketogenic Diet in Combination With Letrozole to Modulate PI3K Signaling in ER+ Breast Cancer
- Status
- COMPLETED
- Phase
- EARLY_PHASE1
Breast Cancer Treatment Based on Organ-like Culture
- Status
- UNKNOWN
- Phase
- N/A
A Window of Opportunity Study of Pre-operative Endocrine Therapy With and Without Prometrium in Postmenopausal Women With Early Stage Breast Hormone Receptor Positive (HR+) Human Epidermal Receptor 2 Negative (HER2-) Breast Cancer.
- Status
- RECRUITING
- Phase
- PHASE2
Palbociclib, Letrozole & Venetoclax in ER and BCL-2 Positive Breast Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
PersonaLized neoAdjuvant Strategy ER Positive and HER2 Negative Breast Cancer TO Increase BCS Rate
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Assessing the Response Rate of Neo-adjuvant Taxotere and Trastuzumab in Nigerian Women With Breast Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Study of 2 Ribociclib Doses in Combination With Aromatase Inhibitors in Women With HR+, HER2- Advanced Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Hydroxychloroquine, Palbociclib, and Letrozole Before Surgery in Treating Patients With Estrogen Receptor Positive, HER2 Negative Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Pyrotinib, Dalpiciclib(SHR6390) and Endocrine Therapy in Subjects With Dual-receptor Positive(ER+/HER2+) Advanced Breast Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
Letrozole in Post-Menopausal Patients With Operable Hormone-Sensitive Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Radiation Therapy, Palbociclib, and Hormone Therapy in Treating Breast Cancer Patients With Bone Metastasis
- Status
- COMPLETED
- Phase
- PHASE2